Related Experiment Video
Updated: Apr 26, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice
Abstract:
Cancer has long been viewed as a genetic disease; however, epigenetic silencing as the result of aberrant promoter DNA methylation is frequently associated with cancer development, suggesting an epigenetic component to the disease. Nonetheless, it has remained unclear whether an epimutation (an aberrant change in epigenetic regulation) can induce tumorigenesis. Here, we exploited a functionally validated cis-acting regulatory element and devised a strategy to induce developmentally regulated genomic targeting of DNA methylation. We used this system to target DNA methylation within the p16(Ink4a) promoter in mice in vivo. Engineered p16(Ink4a) promoter hypermethylation led to transcriptional suppression in somatic tissues during aging and increased the incidence of spontaneous cancers in these mice. Further, mice carrying a germline p16(Ink4a) mutation in one allele and a somatic epimutation in the other had accelerated tumor onset and substantially shortened tumor-free survival. Taken together, these results provide direct functional evidence that p16(Ink4a) epimutation drives tumor formation and malignant progression and validate a targeted methylation approach to epigenetic engineering.
Insights
Epigenetic changes, specifically DNA methylation, can drive cancer development. This study shows that altering methylation of the p16Ink4a gene in mice directly causes tumors, proving epimutations can initiate cancer.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Cancer is often considered a genetic disease, but epigenetic alterations like DNA methylation are frequently observed.
- The role of epimutations (aberrant epigenetic changes) in initiating tumorigenesis remains unclear.
Purpose of the Study:
- To investigate whether an epimutation can directly induce cancer.
- To validate a targeted DNA methylation strategy for epigenetic engineering in vivo.
Main Methods:
- Engineered a system to induce targeted DNA methylation at the p16Ink4a promoter in mice.
- Assessed the impact of induced hypermethylation on gene expression, tumor incidence, and survival.
Main Results:
- Targeted DNA methylation of the p16Ink4a promoter led to transcriptional suppression in aging mice.
- Induced p16Ink4a hypermethylation increased spontaneous cancer incidence.
- Mice with both germline p16Ink4a mutation and somatic epimutation showed accelerated tumor development.
Conclusions:
- Epimutations, specifically in the p16Ink4a gene, can directly drive tumor formation and progression.
- Targeted DNA methylation is a validated approach for epigenetic engineering with implications for cancer research.
More Related Videos
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Replicative Cell Senescence
In-vitro Mutagenesis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity